Fulgent Genetics, Inc.
FLGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $283 | $289 | $619 | $993 |
| % Growth | -2% | -53.3% | -37.6% | – |
| Cost of Goods Sold | $176 | $185 | $252 | $216 |
| Gross Profit | $107 | $104 | $367 | $777 |
| % Margin | 37.8% | 36.1% | 59.3% | 78.3% |
| R&D Expenses | $49 | $41 | $29 | $24 |
| G&A Expenses | $88 | $89 | $111 | $51 |
| SG&A Expenses | $124 | $130 | $150 | $75 |
| Sales & Mktg Exp. | $36 | $41 | $39 | $24 |
| Other Operating Expenses | $8 | $128 | $9 | $2 |
| Operating Expenses | $181 | $300 | $188 | $101 |
| Operating Income | -$74 | -$196 | $179 | $676 |
| % Margin | -26.1% | -67.6% | 28.8% | 68.1% |
| Other Income/Exp. Net | $22 | $21 | $5 | $5 |
| Pre-Tax Income | -$52 | -$174 | $184 | $681 |
| Tax Expense | -$8 | $1 | $42 | $175 |
| Net Income | -$43 | -$168 | $143 | $507 |
| % Margin | -15.1% | -58% | 23.2% | 51.1% |
| EPS | -1.41 | -5.63 | 4.76 | 17.13 |
| % Growth | 75% | -218.3% | -72.2% | – |
| EPS Diluted | -1.41 | -5.63 | 4.63 | 16.26 |
| Weighted Avg Shares Out | 30 | 30 | 30 | 29 |
| Weighted Avg Shares Out Dil | 30 | 30 | 31 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31 | $22 | $6 | $1 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $25 | $26 | $33 | $11 |
| EBITDA | -$49 | -$147 | $218 | $687 |
| % Margin | -17.3% | -51% | 35.2% | 69.2% |